Ftse Mib
38.506,29
-0,03%
DAX
23.153,72
0,15%
S&P 500
5.842,63
1,12%
NASDAQ
18.552,73
1,46%
Bitcoin
90.748,76
0,14%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ COMPASS Pathways PLC (CMPS) COMPASS Pathways PLC (CMPS) Notizie

CMPS

COMPASS Pathways (CMPS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CMPS
DataOraFonteTitoloSimboloCompagnia
05/03/202522:36Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CMPSCOMPASS Pathways PLC
04/03/202523:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CMPSCOMPASS Pathways PLC
27/02/202512:48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CMPSCOMPASS Pathways PLC
27/02/202512:42Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CMPSCOMPASS Pathways PLC
27/02/202512:30Business WireCompass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business HighlightsNASDAQ:CMPSCOMPASS Pathways PLC
27/02/202512:29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMPSCOMPASS Pathways PLC
27/02/202512:28Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CMPSCOMPASS Pathways PLC
25/02/202522:00Business WireCompass Pathways to Participate in TD Cowen 45th Annual Health Care ConferenceNASDAQ:CMPSCOMPASS Pathways PLC
18/02/202512:30Business WireCompass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025NASDAQ:CMPSCOMPASS Pathways PLC
14/02/202503:42Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CMPSCOMPASS Pathways PLC
05/02/202512:30Business WireCompass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences ConferenceNASDAQ:CMPSCOMPASS Pathways PLC
21/01/202512:30Business WireCompass Pathways Appoints Steve Levine, M.D., as Chief Patient OfficerNASDAQ:CMPSCOMPASS Pathways PLC
17/01/202522:02Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CMPSCOMPASS Pathways PLC
10/01/202522:20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CMPSCOMPASS Pathways PLC
10/01/202513:01Business WireCompass Pathways Announces Pricing of Underwritten OfferingNASDAQ:CMPSCOMPASS Pathways PLC
18/12/202412:30Business WireCompass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)NASDAQ:CMPSCOMPASS Pathways PLC
25/11/202422:00Business WireCompass Pathways to Participate in December Investor ConferencesNASDAQ:CMPSCOMPASS Pathways PLC
14/11/202422:35Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CMPSCOMPASS Pathways PLC
31/10/202411:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CMPSCOMPASS Pathways PLC
31/10/202411:30Business WireCompass Pathways Announces Third Quarter 2024 Financial Results and Business UpdatesNASDAQ:CMPSCOMPASS Pathways PLC
24/10/202412:30Business WireCompass Pathways to Announce Third Quarter Financial Results on October 31, 2024NASDAQ:CMPSCOMPASS Pathways PLC
18/10/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CMPSCOMPASS Pathways PLC
28/09/202401:56Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:CMPSCOMPASS Pathways PLC
24/09/202410:43Business WireCompass Pathways nimmt am Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit teilNASDAQ:CMPSCOMPASS Pathways PLC
24/09/202410:42Business WireCompass Pathways participera au Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry SummitNASDAQ:CMPSCOMPASS Pathways PLC
23/09/202413:00Business WireCompass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry SummitNASDAQ:CMPSCOMPASS Pathways PLC
01/08/202412:30GlobeNewswire Inc.Compass Pathways announces second quarter 2024 financial results and business highlightsNASDAQ:CMPSCOMPASS Pathways PLC
26/06/202412:30GlobeNewswire Inc.Compass Pathways appoints Lori Englebert as Chief Commercial OfficerNASDAQ:CMPSCOMPASS Pathways PLC
08/05/202412:45GlobeNewswire Inc.Compass Pathways Announces First Quarter 2024 Financial Results and Business HighlightsNASDAQ:CMPSCOMPASS Pathways PLC
08/05/202412:30GlobeNewswire Inc.Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorderNASDAQ:CMPSCOMPASS Pathways PLC
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CMPS

La tua Cronologia

USOTC
SING
SinglePoint (PK)
BIT
NSCIT1114155
Adidas
AQSE
DSCV.GB
DiscoverIE
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci